See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2022_IONIS_PHARMACEUTICALS_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.7117152036785945, 'aggregate_val': 1839953000, 'exp_sum': 678520000, 'exp_to_value': {'LiabilitiesCurrent': 240550000, 'LiabilitiesNoncurrent': 351879000, 'remainder_Liabilities': 86091000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000874015, IONIS PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,345,049,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 29,005,000 |
| 2 | PropertyPlantAndEquipmentNet | 178,069,000 |
| 3 | remainder_Assets | 59,567,000 |
| 4 | LiabilitiesCurrent | 240,550,000 |
| 5 | LiabilitiesNoncurrent | 351,879,000 |
| 6 | remainder_Liabilities | 1,247,524,000 |
| 7 | CostOfGoodsAndServicesSold | 10,842,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 186,347,000 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 652,251,000 |
| 11 | remainder_Revenues | 810,456,000 |
| 12 | remainder_NetIncome | 10,387,000 |
| 13 | remainder_ComprehensiveNetIncome | -11,597,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,611,690,000 |
| 1 | Liabilities | 1,839,953,000 |
| 2 | Expenses | 849,440,000 |
| 3 | Revenues | 810,456,000 |
| 4 | StockholdersEquity | 771,737,000 |
| 5 | NetIncome | -28,597,000 |
| 6 | ComprehensiveNetIncome | -34,395,500 |
| 7 | BaseVar | 3,066,761,500 |
| 8 | EconomicCapitalRatio | 0.581 |
Edgar->Model Mapping
Feature Distribution
Change over Time
